Clinical Trial Update: Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings [Phase 2]

View source ↗

Summary

A Phase 2 trial led by the University of Oxford is evaluating an earlier Prime-BOOST vaccination schedule to enhance protection against measles in high-burden s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles

Snippet

Sponsor: University of Oxford | Conditions: Measles | Phase 2 | Status: RECRUITING